Israel Englander Immunome Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$11.01 - $27.34 $4.73 Million - $11.7 Million
429,268 Added 1191.82%
465,286 $11.5 Million
Q4 2023

Feb 14, 2024
SELL
$7.3 - $10.73 $218,912 - $321,771
-29,988 Reduced 45.43%
36,018 $385,000
Q2 2023

Aug 14, 2023
SELL
$4.7 - $7.91 $393,126 - $661,624
-83,644 Reduced 55.89%
66,006 $522,000
Q1 2023

May 15, 2023
BUY
$3.26 - $5.69 $487,858 - $851,508
149,650 New
149,650 $747,000

Others Institutions Holding IMNM

# of Institutions
122
Shares Held
47.1M
Call Options Held
322K
Put Options Held
1.91M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $110M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email